NCT04100811View on ClinicalTrials.gov

Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform

Active, not recruitingOBSERVATIONAL
Enrollment

2,019

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Prostate Cancer
Trial Locations (3)

11735

Integrated Medical Professionals, Farmingdale

30281

Urology of Greater Atlanta, Stockbridge

30328

Georgia Urology, Atlanta

All Listed Sponsors
lead

miR Scientific LLC

INDUSTRY

NCT04100811 - Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform | Biotech Hunter | Biotech Hunter